NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 47 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $99,572 | +18.6% | 119,966 | 0.0% | 0.01% | +27.3% |
| Q1 2023 | $83,976 | +36.6% | 119,966 | -0.7% | 0.01% | +22.2% |
| Q4 2022 | $61,469 | -20.2% | 120,764 | +0.3% | 0.01% | -43.8% |
| Q3 2022 | $77,000 | -39.8% | 120,368 | -3.5% | 0.02% | -51.5% |
| Q2 2022 | $128,000 | -51.5% | 124,701 | -11.2% | 0.03% | -61.6% |
| Q1 2022 | $264,000 | -62.8% | 140,508 | -4.4% | 0.09% | -77.3% |
| Q4 2021 | $709,000 | – | 147,000 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,047,300 | $5,048,000 | 1.07% |
| ACT CAPITAL MANAGEMENT, LLC | 212,500 | $1,024,000 | 0.74% |
| Redmile Group, LLC | 3,490,835 | $16,826,000 | 0.38% |
| Kynam Capital Management, LP | 147,000 | $709,000 | 0.38% |
| EcoR1 Capital, LLC | 860,619 | $4,148,000 | 0.13% |
| Baker Brothers Advisors | 3,821,740 | $18,421,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 130,899 | $631,000 | 0.08% |
| Sio Capital Management, LLC | 38,312 | $185,000 | 0.06% |
| Highland Private Wealth Management | 46,999 | $227,000 | 0.03% |
| XTX Topco Ltd | 10,018 | $48,000 | 0.03% |